ORAL LICHEN PLANUS – CURRENT POINT OF VIEW
Authors:
M. Janovská 1; Š. Podzimek 2
Authors place of work:
Oddělení orální medicíny, Stomatologická klinika, 1. lékařská fakulta Univerzity Karlovy
a Všeobecná fakultní nemocnice, Praha
1; Laboratoř pro ústní biologii, Stomatologická klinika, 1. lékařská fakulta Univerzity Karlovy
a Všeobecná fakultní nemocnice, Praha
2
Published in the journal:
Česká stomatologie / Praktické zubní lékařství, ročník 119, 2019, 4, s. 100-111
Category:
Review Article
Summary
Introduction, aim: Oral lichen planus is one of the most common diseases of the oral mucosa. It is present in approximately 0,5%–2% of population. Despite the large number of scientific papers focused on oral lichen planus, the etiology of the disease remains unclear. There are several basic forms, the most common being the reticular form. The subjective symptoms associated with oral lichen planus can vary considerably from minimal symptomatology to severe pain in affected tissues, including problems with speaking, food intake or oral hygiene procedures. The risk of malignant transformation of oral lichen planus / lichenoid lesions has been studied in various ways and still figures as a subject that has been addressed by a number of experts in various fields of medicine. Some manifestations resembling of oral lichen planus are classified as lichenoid drug eruptions, contact lesions, and lichenoid stomatitis in graft versus host disease, while other cases are defined as idiopathic lichen planus where the cause is unknown. The aim of this publication is to present current knowledges concerning oral lichen planus and lichenoid stomatitis.
Methods: PubMed databasis publications focused on risk factors, malignant potential and therapeutic options of oral lichen planus and lichenoid stomatitis have been critically reviewed. Great emphasis was put on suspicious risk factors and risk of malignant transformation and therapeutic options for these diseases.
Results: Oral lichen planus is a chronic disease that can lead to a significant limitation of life. The diagnosis of oral lichen planus is always based on proper clinical examination and histopathological characteristics. Diagnosing of this disease only on a clinical or histopathological basis can lead to a significant percentage of diagnostic errors. This may have fatal consequences, especially in the absence of exclusion of other potentially malignant diseases that can often imitate lichen planus, lichenoid stomatitis respectively, at clinical level, but ultimately have a different course. Thus, as far as possible, the unambiguous clinical and histopathological definition of oral lichen planus and lichenoid stomatitis is the crucial moment of the entire diagnostic algorithm.
Conclusion: Research activities in this field are supported primarily by scientific work dealing with the possible malignant transformation of oral lichen planus and the extension of therapeutic options. Current trend of scientific approaches is to support this tendency.
Keywords:
therapy – histopathology – oral lichen planus – lichenoid stomatitis – oral mucosa
Zdroje
1. Carrozzo M, Thorpe P.
Oral lichen planus. A review. Minerva Stomatol. 2009; 58: 519–537.
2. Giuliani M, Troiano G, Cordaro M. Rate of malignant transformation of oral lichen planus: A systematic review.
Oral Dis. 2018; 25: 693–709.
3. Carrozzo M, Gandolfo S.
The management of oral lichen planus.
Oral Dis. 1999; 5: 196–205.
4. Carrozzo M, Gandolfo S, Carbone M.
Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med. 1996; 25: 527–533.
5. Axéll T. Hypersensitivity of the oral mucosa: clinics and pathology. Acta Odontol Scand. 2000; 5: 315–319.
6. Al-Hashimi I, Schifter M, Lockhart PB. Oral lichen planus and lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 103: S25e1–S25e12.
7. Alves MGO, Balducci I, Carvalho YR, Nunes FD, Almeida JD. Oral lichen planus: a histopathological study. Histopathology. 2015; 66: 463–464.
8. Au J, Patel D, Campbell JH. Oral lichen planus. Oral Maxillofac Surg Clin North Am. 2013; 25: 93–100.
9. Henriksson E, Mattsson U, Hakansson J. Healing of lichenoid reactions following removal of amalgam. J Clin Periodontol. 1995; 22: 287–294.
10. McCartan BE, Mccreary CE. Oral lichenoid drug eruptions. Oral Dis. 1997; 3: 58–63.
11. Scully C, Beyli M, Ferreiro MC, Ficarra G, Gill Y, Griffiths M, Holmstrup P, Mutlu S, Porter S, Wray D. Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med. 1998; 9: 86–122.
12. Roopashree M, Gondhalekar R, Shashikanth M, George J, Thippeswamy SH, Shukla A. Pathogenesis of oral lichen planus – a review. J Oral Pathol Med. 2010; 39(10): 729–734.
13. Korstanje MJ. Drug-induced mouth disorders. Clin Exp Dermatol. 1995; 20: 10–18.
14. Dřízhal I, Paulusová V. Orální lichen planus – současné poznatky. Čes stomatol Prakt zubní lék. 2008; 108(2): 35–38.
15. Walsh LJ, Savage NW, Ishii T. Immunopathogenesis of oral lichen planus. J Oral Pathol Med. 1990; 19: 389–396.
16. Lodi G, Carrozzo M, Furness S, Thongprasom K. Interventions for treating oral lichen planus: A systematic review. Br J Dermatol. 2012; 166: 938–947.
17. Adreasen JO. Oral lichen planus. 1. A clinical evaluation of 115 cases. Oral Surg Oral Med Oral Pathol. 1968; 25: 31–42.
18. Alberdi-Navarro J, Marichalar-Mendia, Lartitegui-Sebastián MJ, Gainza-Cirauqui ML, Echebarria-Goikouria MA, Aguirre-Urizar JM. Histopathological characterization of the oral lichenoid disease subtypes and the relation with clinical data. Med Oral Patol Oral Cir Bucal. 2017; 3: 307–313.
19. Firth NA, Rich AM, Radden B, Reade PC. Assessment of the value of immunofluorescence microscopy in the diagnosis of oral lichen planus. J Oral Pathol Med. 1990; 219: 295–297.
20. Lage D, Juliano PB, Metze K, de Souza EM, Cintra ML. Lichen planus and lichenoid drug-induced eruption: a histological and imunohistochemical study. Int J Dermatol. 2012; 51: 1199–1205.
21. Sanchez-Perez J, Castro M, Buezo GF, Fernandez-Herrera J, Borque MJ, Garcia-Diez A. Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol. 1996; 134: 715–719.
22. Bagan JV, Ramon C, Gonzales L. Preliminary investigation of the association of oral lichen planus and hepatitis. Oral Surg Oral Med Oral Pathol. 1998; 85: 532–536.
23. Bellman B, Reddy RK, Falanga V. Lichen planus associated with hepatitis C. Lancet. 1995; 346: 1234.
24. Chuang TY, Stitle L, Brashear R, Lewis C. Hepatitis C virus and lichen planus: a case control study. J Am Acad Dermatol. 1999; 41: 787–789.
25. Beaird LM, Kahloon N, Franco J, Fairley JA. Incidence of hepatitis C in lichen planus. J Am Acad Dermatol. 2001; 44: 311–312.
26. Kirby AC, Lodi GL, Olsen I, Porter SR. Immunohistochemical and serological comparison of idiopathic and hepatitis C virus-associated forms of oral lichen planus. Eur J Epidemiol. 1998; 16: 853–862.
27. Manolache L, Seceleanu-Petrescu D, Benea V. Lichen planus patients and stressful events. JEADV. 2008; 22: 437–441.
28. Koo JYM, Pham CT. Psychodermatology: Practical guidelines on pharmacotherapy. Arch Dermatol. 1992; 128: 381–388.
29. Chaudhary S. Psychosocial stressors in oral lichen planus. Aust Dent J. 2004; 4: 192–195.
30. Ivanovski K, Nakova M, Warburton G, Pesevska S, Filipovska A, Nares S, Nunn ME, Angelova D, Angelov N. Psychological profile in oral lichen planus. J Clin Periodontol. 2005; 32: 1034–1040.
31. Preda EG, Passeti P, Caggiula S, Nidoli G, Boggio E, Azzi R. Oral pathology of psychosomatic origin. Review of the literature. Dent Cadmos. 1990; 58: 66–72.
32. Eversole LR. Cellular immune correlates of clinical severity in oral lichen planus: preliminary association with mood states. Oral Dis. 1997; 3: 64–70.
33. Koray M, Dulger O, Horasanli S, Ucok A, Tanyeri H, Badur S. The evaluation of axiety and salivary cortisol levels in patients with oral lichen planus. Oral Dis. 2003; 9: 298–301.
34. Habbab KM, Moles DR, Porter SR. Potential oral manifestations of cardiovascular drugs. Oral Dis. 2010; 16: 769–773.
35. Ingelman-Sundberg M. Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes. Mutat Res. 2001; 482: 11–19.
36. Roblero-Sierra J, Mattsson U, Jontell M. Use of systemic medication in patients with oral lichen planus – a possible association with hypothyroidism. Oral Dis. 2013; 19: 313–319.
37. Schlosser B. Lichen planus and lichenoid reactions of the oral mucosa. Dermatol Ther. 2010; 23: 251–267.
38. Scully C, Carrozzo M. Oral mucosal disease: lichen planus. Oral Dis. 2008; 46: 15–21.
39. Gunes AT, Fetil E, Ilknur T, Birgin B, Ozkan S. Naproxen-induced lichen planus: report of 55 cases. Pediatr Dermatol. 2009; 26: 458–464.
40. Scott A, Egner W, Gawkrodger DJ, Hatton PV, Sherriff M, van Noort R, Yeoman C, Grummitt J. The national survey of adverse reactions to dental materials in the UK: a preliminary study by UK Adverse Reactions Reporting Project. Br Dent J. 2004; 8: 471–477.
41. Barbucci R. Integrated biomaterials science. Springer Science & Business Media, 2007.
42. Lohmann CH, Hameister R, Singh G. Allergies in ortopaedic and trauma surgery. Orthopaedics Traumatology. Surg Res. 2017; 103: 75–81.
43. Koch P, Bahmer FA. Oral lichenoid lesions, mercury hypersensitivity and combined hypersensitivity to mercury and other metals: histologically-proven reproduction of the reaction by patch testing with metal salts. Contact Dermat. 1995; 5: 323–328.
44. Prochazkova J, Sterzl I, Kucerova H, Bartova J, Stejskal VDM. The beneficial effect of amalgam replacement on health in patients with autoimmunity. Neuroendocrinol Lett. 2004; 25(3): 211–218.
45. Stejskal J, Stejskal VDM. The role of metals in autoimmunity and the link to neuroendocrinology. Neuroendocrinol Lett. 1999; 20: 351–364.
46. Rai R. Hypersensitivity of the oral mucosa: clinics and pathology. Indian Dermatol Online J. 2014; 3: 282–286.
47. Lamey PJ, McCartan BE, Macdonald DG.
Basal cell cytoplasmic autoantibodies in oral lichenoid reactions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995; 79: 44–49.
48. Kramer IR, Lucas RB, Pindborg JJ, Sobin LH. Definition of leukoplakia and related lesions: an aid to studies on oral cancer. Oral Surg Oral Med Oral Pathol. 1978; 45: 518–539.
49. Shirasuna K. Oral lichen planus: Malignant potential and diagnosis. Oral Sci Int. 2014; 11: 1–7.
50. Van der Meiji E, Van der Wall I. Lack of clinicopathological correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med. 2003; 32(9), 507–512.
51. Gonzales-Moles MA, Scully C, Gil-Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis. 2008; 14: 229–243.
52. Mignogna MD, Lomuzio L, Favia G, Mignogna RE, Carbone R, Bucci E. Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. Int J Dermatol. 1998; 37: 575–578.
53. Gandolfo S, Richiardi L, Carrozzo M, Broccoletti R, Carbone M, Pagano M, Vestita C, Rosso S, Merletti F. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol. 2004; 40: 77–83.
54. Mattson U, Jontell M, Holmstrup P. Oral lichen planus and malignant transformation: is a recall of patients justified? Crit Rev Oral Biol Med. 2002; 13: 390–396.
55. Greenberg M. AAOM Clinical Practise Statement, subject: Oral lichen planus and oral cancer, 2016.
56. Yang H, Wu Y, Ma H, Jiang L, Zeng X, Dan H, Zhou Y, Chen Q. Possible alternative therapies for oral lichen planus cases refractory to steroid therapies. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 121: 496–509.
57. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005; 100: 40–51.
58. Gutfreund K, Bienias W, Szewczyk A, Kaszuba A. Topical calcineurin inhibitors in dermatology. Postepy Dermatol Alergol. 2013; 30: 65–169.
59. Georgakopoulou EA, Scully C. Systemic use of non-biologic agents in orofacial diseases: other immunomodulatory agents. Oral Dis. 2015; 21: 273–282.
60. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell-carcinoma. Mol Cancer. 2011; 10: 1–19.
61. Rai B, Kaur J, Jacobs R. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. J Oral Sci. 2010; 52: 251–256.
62. Cafaro A, Arduino PG, Massolini G, Romagnoli E, Broccoletti R. Clinical evaluation of the efficiency of low-level laser therapy for oral lichen planus: a prospective case series. Lasers Med Sci. 2014; 29: 185–190.
63. Carrozzo M. Oral health in patients with hepatitis C virus infection: an underestimated problem? Oral Dis. 2001; 7: 267–270.
64. Krutschkoff DJ, Cutler L, Laskowski S. Oral lichen planus: the evidence regarding potential malignant transformation. J Oral Pathol. 1978; 7: 1–7.
65. Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systema-tic review. J Am Dent Assoc. 2014; 145: 45–56.
66. Cheng Y-SL, Gould A, Kurago Z, Fantasia J, Muller S. Diagnosis of oral lichen planus: a position paper of American Academy of Oral and Maxillofacial Pathology. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016; 122: 332–354.
67. Sarkar R, Chugh S, Garg VK. Acitretin in dermatology. Indian J Dermatol Venereol Leprol. 2013; 79: 759–771.
68. Soto Araya M, Rojas Alcayaga G, Esguep A. Association between psychological disorders and the presence of oral lichen planus, burning mouth syndrom and recurrent aphthous stomatitis. Med Oral. 2004; 9: 1–7.
69. Valentine-Thon E, Muller K, Guzzi G, Kreisel S, Ohnsorge P, Sandkamp M. LTT-MELISSA© is clinically relevant for detecting and monitoring metal sensitivity. Neuro Endocrinol Lett. 2006; 27: 17–24.
70. Rai R, Dinakar D, Kurian SS, Bindoo YA. Investigation of contact allergy to dental materials by patch testing. Indian Dermatol Online J. 2014; 3: 282–286.
71. Thongprasom K. Novel therapies for oral lichen planus. J Oral Pathol Med. 2013; 42: 721–727.
72. Valentine-Thon E, Sandkamp M, Muller K, Guzzi G, Hartmann T. Metallsensibilisierung: nachweis, validierung und verlaufskontrolle mittels lymphocyten--transformations-test (LTT-MELISA©). OM Zs Orthomol Med. 2005; 20: 12–15.
73. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Lichen planus and liver diseases: a multicente case-control study. BMJ; 300: 227–230.
Štítky
Maxillofacial surgery Orthodontics Dental medicineČlánok vyšiel v časopise
Czech Dental Journal
2019 Číslo 4
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
Najčítanejšie v tomto čísle
- ORAL LICHEN PLANUS – CURRENT POINT OF VIEW
- Prosthetic restoration of missing upper canine, In the case of buccaly tilted implant